HOME >> BIOLOGY >> NEWS
From basic science to the bedside: APS conference takes stock of lung disease

BETHESDA, MD When researchers completed the human genome map in 2000, they still faced a complex puzzle: What role does each of the 24,000 human genes and the thousands more proteins they produce, play in various illnesses?

Researchers and medical doctors who deal with lung disease will take stock of the progress toward answering that question at The American Physiological Society conference "Physiological Genomics and Proteomics of Lung Disease," Nov. 2-5 in Fort Lauderdale, Florida. The conference comes amid giant leaps in knowledge of genes and proteins and also in the face of recent advances in bioinformatics (the use of computer hardware and software to analyze large amounts of biological information).

It is now possible to find the proverbial needle in a haystack by analyzing "tons of data," said J. Usha Raj, the chief of neonatology at Harbor-UCLA Medical Center, professor of pediatrics at the UCLA Geffen School of Medicine and chair of the conference organizing committee. Scientists are using these advances to identify the genes and proteins implicated in diseases such as asthma and chronic obstructive pulmonary disorder (COPD), she said.

"This is a conference where the latest advances in computer technology, genomics (the study of the hereditary information encoded in the DNA) and proteomics (the study of proteins, which the genes instruct the body to produce) are being applied to the treatment and prevention of diseases," Raj noted. "We have doctors who want to jump in and take these basic science advances to the bedside."

The conference will "provide a relaxed environment where established researchers and young investigators alike can present and examine the most recent experimental discoveries and discuss ways to translate these discoveries for clinical use," the organizers said. Researchers and clinicians can use the information to fight diseases such as:

  • Asthma, a chronic disease in which the inside wall
    '"/>


Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
20-Jun-2006


Page: 1 2 3

Related biology news :

1. Male contraception -- UVa discovery stirring interest among basic scientists and drug developers
2. Scientists discover basic defect in cystic fibrosis airway glands
3. Bridging the gap between basic science and medical practice
4. Getting down to basicsnew technology will make it possible
5. New findings lead researchers to question basic assumptions of fisheries management
6. New research questions basic tenet of neuron function
7. IRCM scientist demonstrates basic active mechanism of immune-system cells
8. Study describes basic mechanism in cell growth control involving damaged DNA
9. Research out this week helps us understand basics of how neurons communicate
10. AFCYBER holds science and technology symposium
11. News tips from the Journal of Neuroscience

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: From basic science the bedside APS conference takes stock lung disease

(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: